BIOMES

About:

BIOMES is a biotechnological pioneer that specializes in improving everyones wellbeing by analyzing and interpreting the human microbiome.

Website: https://www.BIOMES.world

Twitter/X: BIOMESworld

Top Investors: Yabeo, EXIST, GPS Ventures GmbH, Keiyo Gas

Description:

BIOMES is a combining biotech & digital healthcare company based in Germany, whose mission is to improve the lives of all people by helping them to better understand their body on the basis of their DNA, i.e. the human genome and the microbiome. BIOMES distributes its first direct-to-customer product INTEST.pro, an intestinal-flora analysis kit designed to help customers learn about their intestinal flora and its impact on their lives so they can restore their intestinal balance using natural methods. Behind BIOMES is a team of passionate and experienced scientists. BIOMES is built on the basis of years of research work with the goal of making cutting-edge technologies accessible to everyone. Their vision: BIOMES wants to help people live healthier lives. To achieve this, BIOMES combines advanced technologies with the latest scientific findings to create simple tests for use at home. They develop tools that combine cutting-edge biotech methods, scientific evidence and user-friendliness. After several years of research, they spun off from the Technical University of Applied Sciences Wildau in 2017 with a grant and launched our first product not long after: The multi-award-winning intestinal test INTEST.pro helps their customers get to know their intestinal bacteria and sort out personal weak points with personalised nutritional recommendations. Their technology platform, which is able to analyse any DNA on this planet, offers almost unlimited possibilities for developing new products.